This analysis demonstrated that the expression levels of GPX4 and TfR1 can vary between thyroid cancer cell lines (Fig. 1C,D), suggesting underlying tumor heterogeneity at play, and that the GPX4 and TfR1 basal expressions may not serve as reliable markers in vitro. This evidence concerns the gene GPX4 and thyroid gland carcinoma.